Lilly Announces Q1 2026 Financial Results

Pharmaceutical giant Eli Lilly to hold conference call on April 30th to discuss quarterly earnings.

Apr. 17, 2026 at 6:07am

Got story updates? Submit your updates here. ›

A highly detailed, cinematic close-up photograph of the complex mechanical and electronic components that make up a piece of industrial banking or financial equipment, conveying a sense of the intricate machinery that powers the financial industry.Lilly's Q1 2026 earnings report and conference call will provide a detailed look at the inner workings of the pharmaceutical giant's financial operations.Indianapolis Today

Eli Lilly and Company, a leading pharmaceutical company, has announced that it will release its first-quarter 2026 financial results on April 30, 2026. The company will also hold a conference call that day to discuss the results with the investment community and media.

Why it matters

As one of the largest pharmaceutical companies in the world, Lilly's quarterly financial performance is closely watched by investors and industry analysts. The company's earnings report and conference call provide insights into the state of the pharmaceutical industry, Lilly's product pipeline, and the overall health of the company.

The details

Lilly will announce its Q1 2026 financial results on April 30, 2026 and will hold a conference call at 10 a.m. Eastern time that same day. The call will be webcast live on Lilly's website, and a replay will also be available on the site following the call.

  • Lilly will announce Q1 2026 financial results on April 30, 2026.
  • Lilly will hold a conference call at 10 a.m. Eastern time on April 30, 2026 to discuss the results.

The players

Eli Lilly and Company

A leading global pharmaceutical company that develops and markets medicines to treat a wide range of diseases and conditions.

Got photos? Submit your photos here. ›

What’s next

Investors and analysts will be closely watching Lilly's Q1 2026 earnings report and conference call for insights into the company's performance, product pipeline, and overall industry trends.

The takeaway

Lilly's quarterly financial results are a closely watched indicator of the health of the pharmaceutical industry. The company's conference call will provide valuable information to investors and the public about Lilly's business and the broader market.